Systemic lupus erythromatosus presenting as cardiac tamponade: a rare and life-threatening presentation

Darpan Kothia; Madhvi Nagar; Parthkumar Nandania; S. S. Chatterjee

doi:10.18203/2320-6012.ijrms20243397

Authors

Darpan Kothia Department of Internal Medicine, Shri M. P. Shah Medical College, Jamnagar, Gujarat, India
Madhvi Nagar Shri M. P. Shah Medical College, Jamnagar, Gujarat, India
Parthkumar Nandania Jonelta Foundation School of Medicine, University of Perpetual Help System Dalta, Jamnagar, Gujarat, India
S. S. Chatterjee Medicine, Shri M.P. Shah Medical College, Jamnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243397

Keywords:

Cardiac tamponade, Case Report, SLE

Abstract

We present a case of a 35-year-old female with 3-4 months history of left sided chest pain, low grade fever, dyspnea on exertion, dry cough, fatigue and myalgia. Initial investigations including pleural fluid CBNAAT was negative. Empiric anti- tuberculosis therapy was initiated based on clinical and radiological findings. Despite treatment, symptoms persisted. Subsequent evaluation including echocardiography which showed moderate pericardial effusion along with special investigations leading to a diagnosis of systemic lupus erythematosus. Treatment with corticosteroid resulted in significant symptom improvement. This case highlights the importance of considering systemic lupus erythematosus in patients with atypical presentations, even in absence of classic features.

Metrics

Metrics Loading ...

References

Oshiro AC, Derk CT, Magder L, Singh H, Kamen DL, Belmont HM. Cardiac tamponade in patients with systemic lupus erythematosus: A systematic review. QJM. 2015;108:557-63.

Zhao D, Wen Z, Zhang Y, Li Y. Cardiac tamponade as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Pediatr Rheumatol 2017;15:35.

Wallace DJ, Hahn BH. Dubois' Lupus Erythematosus and Related Syndromes. 9th ed. Philadelphia, PA: Elsevier. 2018. Available at: https://www.elsevier.com/books. Accessed on 8th July 2024.

Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64:797-808.

Bertsias G, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Cervera R, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69:2074-82.

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316-53.

Urowitz MB, Gladman DD, Ibanez D, Bae SC, Sanchez-Guerrero J, Gordon C, et al. Evolution of disease burden over five years in a multicentre inception systemic lupus erythematosus cohort. Arthritis Care Res. 2012;64:132-7.

D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369:587-96.

Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore). 1993;72:113-24.

Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46:2121-31.